Research & Innovation
Boston Children's Hospital and Dana-Farber Cancer Institute researchers are actively collecting voluntary samples of blood and bone marrow from patients with aplastic anemia and other bone marrow failure syndromes in order to better understand genetic contributions and molecular aspects of the diseases.
Currently, researchers are exploring possible genetic factors that put children at risk of developing aplastic anemia. Using skin cells and bone marrow cells from patients with aplastic anemia, they will use specialized techniques to compare their genetic material and look for genetic abnormalities in the bone marrow cells.
For more information about current research, visit our Fanconi Anemia and Bone Marrow Failure Multidisciplinary Clinic and our Pediatric Myelodysplastic Syndrome Speciality Care Clinic.